Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Cunningham

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Journal of Cardiac Failure|May 22, 2026
Prognostic Significance of Large Language Model-Extracted Clinical Features at admission for Heart Failure: Insights from DELIVER and PARAGON-HFSamarra Badrouchi, Pablo M Marti-Castellote, Alberto Foà, et al.
Journal of the American College of Cardiology|January 6, 2026
Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical TrialsPablo M Marti-Castellote, Samarra Badrouchi, Brian Claggett, et al.
JACC. Heart Failure|March 16, 2020
Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HFJonathan W Cunningham, João Pedro Ferreira, Hsiaowei Deng, et al.
Journal of the American College of Cardiology|November 6, 2024
Artificial Intelligence in Cardiovascular Clinical TrialsJonathan W Cunningham, William T Abraham, Ankeet S Bhatt, et al.
European Journal of Heart Failure|May 16, 2025
Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trialJonathan W Cunningham, Brian L Claggett, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology|April 2, 2025
New Threshold for Defining Mild Aortic Stenosis Derived From Velocity-Encoded MRI in 60,000 IndividualsShinwan Kany, Joel T Rämö, David Playford, et al.
Journal of the American College of Cardiology|August 1, 2020
Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEFJonathan W Cunningham, Brian L Claggett, Eileen O'Meara, et al.
JACC. Heart Failure|May 11, 2020
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical TrialsJonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
JAMA Cardiology|March 30, 2025
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical TrialAkshay S Desai, Pardeep S Jhund, Muthiah Vaduganathan, et al.
The American Journal of Cardiology|February 4, 2021
Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study)Aliza Hussain, Olive Tang, Caroline Sun, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Journal of Cardiac Failure|May 22, 2026
Prognostic Significance of Large Language Model-Extracted Clinical Features at admission for Heart Failure: Insights from DELIVER and PARAGON-HFSamarra Badrouchi, Pablo M Marti-Castellote, Alberto Foà, et al.
Journal of the American College of Cardiology|January 6, 2026
Using Artificial Intelligence to Adjudicate Major Adverse Cardiovascular Events in Clinical TrialsPablo M Marti-Castellote, Samarra Badrouchi, Brian Claggett, et al.
JACC. Heart Failure|March 16, 2020
Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HFJonathan W Cunningham, João Pedro Ferreira, Hsiaowei Deng, et al.
Journal of the American College of Cardiology|November 6, 2024
Artificial Intelligence in Cardiovascular Clinical TrialsJonathan W Cunningham, William T Abraham, Ankeet S Bhatt, et al.
European Journal of Heart Failure|May 16, 2025
Effects of finerenone on natriuretic peptide levels in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trialJonathan W Cunningham, Brian L Claggett, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology|April 2, 2025
New Threshold for Defining Mild Aortic Stenosis Derived From Velocity-Encoded MRI in 60,000 IndividualsShinwan Kany, Joel T Rämö, David Playford, et al.
Journal of the American College of Cardiology|August 1, 2020
Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEFJonathan W Cunningham, Brian L Claggett, Eileen O'Meara, et al.
JACC. Heart Failure|May 11, 2020
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical TrialsJonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
JAMA Cardiology|March 30, 2025
Mode of Death in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Randomized Clinical TrialAkshay S Desai, Pardeep S Jhund, Muthiah Vaduganathan, et al.
The American Journal of Cardiology|February 4, 2021
Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study)Aliza Hussain, Olive Tang, Caroline Sun, et al.
Pageof 8